Global Peripheral Parenteral Nutrition (PPN) Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08252306

Publication Date:

August 16, 2024

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Peripheral Parenteral Nutrition (PPN) market size was valued at US$ million in 2023. With growing demand in downstream market, the Peripheral Parenteral Nutrition (PPN) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Peripheral Parenteral Nutrition (PPN) market. Peripheral Parenteral Nutrition (PPN) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peripheral Parenteral Nutrition (PPN). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peripheral Parenteral Nutrition (PPN) market.
Key Features:
The report on Peripheral Parenteral Nutrition (PPN) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peripheral Parenteral Nutrition (PPN) market. It may include historical data, market segmentation by Type (e.g., Carbohydrates, Parenteral Lipid Emulsion), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peripheral Parenteral Nutrition (PPN) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peripheral Parenteral Nutrition (PPN) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peripheral Parenteral Nutrition (PPN) industry. This include advancements in Peripheral Parenteral Nutrition (PPN) technology, Peripheral Parenteral Nutrition (PPN) new entrants, Peripheral Parenteral Nutrition (PPN) new investment, and other innovations that are shaping the future of Peripheral Parenteral Nutrition (PPN).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peripheral Parenteral Nutrition (PPN) market. It includes factors influencing customer ' purchasing decisions, preferences for Peripheral Parenteral Nutrition (PPN) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peripheral Parenteral Nutrition (PPN) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peripheral Parenteral Nutrition (PPN) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peripheral Parenteral Nutrition (PPN) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peripheral Parenteral Nutrition (PPN) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peripheral Parenteral Nutrition (PPN) market.
Market Segmentation:
Peripheral Parenteral Nutrition (PPN) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Segmentation by application
Hospital
Home
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc.
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peripheral Parenteral Nutrition (PPN) Market Size 2019-2030
2.1.2 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Peripheral Parenteral Nutrition (PPN) Segment by Type
2.2.1 Carbohydrates
2.2.2 Parenteral Lipid Emulsion
2.2.3 Single Dose Amino Acid Solution
2.2.4 Trace Elements
2.2.5 Vitamins and Minerals
2.3 Peripheral Parenteral Nutrition (PPN) Market Size by Type
2.3.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Type (2019-2024)
2.4 Peripheral Parenteral Nutrition (PPN) Segment by Application
2.4.1 Hospital
2.4.2 Home
2.5 Peripheral Parenteral Nutrition (PPN) Market Size by Application
2.5.1 Peripheral Parenteral Nutrition (PPN) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Application (2019-2024)
3 Peripheral Parenteral Nutrition (PPN) Market Size by Player
3.1 Peripheral Parenteral Nutrition (PPN) Market Size Market Share by Players
3.1.1 Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2019-2024)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Players (2019-2024)
3.2 Global Peripheral Parenteral Nutrition (PPN) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peripheral Parenteral Nutrition (PPN) by Regions
4.1 Peripheral Parenteral Nutrition (PPN) Market Size by Regions (2019-2024)
4.2 Americas Peripheral Parenteral Nutrition (PPN) Market Size Growth (2019-2024)
4.3 APAC Peripheral Parenteral Nutrition (PPN) Market Size Growth (2019-2024)
4.4 Europe Peripheral Parenteral Nutrition (PPN) Market Size Growth (2019-2024)
4.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Country (2019-2024)
5.2 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024)
5.3 Americas Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Region (2019-2024)
6.2 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024)
6.3 APAC Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peripheral Parenteral Nutrition (PPN) by Country (2019-2024)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024)
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) by Region (2019-2024)
8.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Type (2019-2024)
8.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Peripheral Parenteral Nutrition (PPN) Market Forecast
10.1 Global Peripheral Parenteral Nutrition (PPN) Forecast by Regions (2025-2030)
10.1.1 Global Peripheral Parenteral Nutrition (PPN) Forecast by Regions (2025-2030)
10.1.2 Americas Peripheral Parenteral Nutrition (PPN) Forecast
10.1.3 APAC Peripheral Parenteral Nutrition (PPN) Forecast
10.1.4 Europe Peripheral Parenteral Nutrition (PPN) Forecast
10.1.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Forecast
10.2 Americas Peripheral Parenteral Nutrition (PPN) Forecast by Country (2025-2030)
10.2.1 United States Peripheral Parenteral Nutrition (PPN) Market Forecast
10.2.2 Canada Peripheral Parenteral Nutrition (PPN) Market Forecast
10.2.3 Mexico Peripheral Parenteral Nutrition (PPN) Market Forecast
10.2.4 Brazil Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3 APAC Peripheral Parenteral Nutrition (PPN) Forecast by Region (2025-2030)
10.3.1 China Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3.2 Japan Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3.3 Korea Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3.4 Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3.5 India Peripheral Parenteral Nutrition (PPN) Market Forecast
10.3.6 Australia Peripheral Parenteral Nutrition (PPN) Market Forecast
10.4 Europe Peripheral Parenteral Nutrition (PPN) Forecast by Country (2025-2030)
10.4.1 Germany Peripheral Parenteral Nutrition (PPN) Market Forecast
10.4.2 France Peripheral Parenteral Nutrition (PPN) Market Forecast
10.4.3 UK Peripheral Parenteral Nutrition (PPN) Market Forecast
10.4.4 Italy Peripheral Parenteral Nutrition (PPN) Market Forecast
10.4.5 Russia Peripheral Parenteral Nutrition (PPN) Market Forecast
10.5 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Forecast by Region (2025-2030)
10.5.1 Egypt Peripheral Parenteral Nutrition (PPN) Market Forecast
10.5.2 South Africa Peripheral Parenteral Nutrition (PPN) Market Forecast
10.5.3 Israel Peripheral Parenteral Nutrition (PPN) Market Forecast
10.5.4 Turkey Peripheral Parenteral Nutrition (PPN) Market Forecast
10.5.5 GCC Countries Peripheral Parenteral Nutrition (PPN) Market Forecast
10.6 Global Peripheral Parenteral Nutrition (PPN) Forecast by Type (2025-2030)
10.7 Global Peripheral Parenteral Nutrition (PPN) Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Eurofarma
11.1.1 Eurofarma Company Information
11.1.2 Eurofarma Peripheral Parenteral Nutrition (PPN) Product Offered
11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Eurofarma Main Business Overview
11.1.5 Eurofarma Latest Developments
11.2 Corporacion De Laboratorios Farmaceuticos
11.2.1 Corporacion De Laboratorios Farmaceuticos Company Information
11.2.2 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product Offered
11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Corporacion De Laboratorios Farmaceuticos Main Business Overview
11.2.5 Corporacion De Laboratorios Farmaceuticos Latest Developments
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Information
11.3.2 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product Offered
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Baxter International Inc. Main Business Overview
11.3.5 Baxter International Inc. Latest Developments
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Information
11.4.2 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product Offered
11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Kelun Pharma Main Business Overview
11.4.5 Kelun Pharma Latest Developments
11.5 B. Braun
11.5.1 B. Braun Company Information
11.5.2 B. Braun Peripheral Parenteral Nutrition (PPN) Product Offered
11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 B. Braun Main Business Overview
11.5.5 B. Braun Latest Developments
11.6 Fresenius
11.6.1 Fresenius Company Information
11.6.2 Fresenius Peripheral Parenteral Nutrition (PPN) Product Offered
11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Fresenius Main Business Overview
11.6.5 Fresenius Latest Developments
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Information
11.7.2 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product Offered
11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Teva Pharmaceutical Industries Main Business Overview
11.7.5 Teva Pharmaceutical Industries Latest Developments
11.8 Pfizer (Hospira)
11.8.1 Pfizer (Hospira) Company Information
11.8.2 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product Offered
11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer (Hospira) Main Business Overview
11.8.5 Pfizer (Hospira) Latest Developments
11.9 Ostuka Pharmaceutical
11.9.1 Ostuka Pharmaceutical Company Information
11.9.2 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product Offered
11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Ostuka Pharmaceutical Main Business Overview
11.9.5 Ostuka Pharmaceutical Latest Developments
11.10 Laboratorios Biogalenic
11.10.1 Laboratorios Biogalenic Company Information
11.10.2 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product Offered
11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Laboratorios Biogalenic Main Business Overview
11.10.5 Laboratorios Biogalenic Latest Developments
11.11 Laboratorios Finlay
11.11.1 Laboratorios Finlay Company Information
11.11.2 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product Offered
11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Laboratorios Finlay Main Business Overview
11.11.5 Laboratorios Finlay Latest Developments
11.12 Grifols International
11.12.1 Grifols International Company Information
11.12.2 Grifols International Peripheral Parenteral Nutrition (PPN) Product Offered
11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Grifols International Main Business Overview
11.12.5 Grifols International Latest Developments
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Information
11.13.2 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product Offered
11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Fresenius Kabi Main Business Overview
11.13.5 Fresenius Kabi Latest Developments
11.14 Sichuan Kelun Pharmaceutical
11.14.1 Sichuan Kelun Pharmaceutical Company Information
11.14.2 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product Offered
11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Sichuan Kelun Pharmaceutical Main Business Overview
11.14.5 Sichuan Kelun Pharmaceutical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂